Presenter: Jason Liu, PhD, Field Application Scientist, Roche Sequencing & Life Science
Join us for our upcoming webinar where we will provide an overview of how NGS technologies are advancing our understanding of the SARS-CoV-2 virus and the COVID-19 pandemic. We will review:
Presenter: Mariana Fitarelli Kiehl, PhD, Sr. Applications Scientist, Roche Sequencing & Life Science
Providing targeted next-generation sequencing (NGS) results faster is a common challenge facing labs today. By reducing the time required for hybridization from 16 hours to less than an hour—without compromising performance—you can dramatically increase your lab’s productivity.
In this webinar, we will:
Presenter: Eleanor Cowley, M.S., Sr. NGS Field Automation Scientist, Roche Sequencing & Life Science
Automating RNA-sequencing (RNA-seq) library preparation offers advantages such as higher sample throughput, less hands-on time, fewer human errors, greater reproducibility, and better process control and workflow standardization. However, developing and implementing an automated RNA-seq library prep protocol on a liquid handling platform can be challenging and time-consuming.
In this webinar, we discussed the automation of RNA-seq library prep, including:
Presenter: Ranjit Kumar, Ph.D. Sr. Bioinformatics Scientist, Roche Sequencing and Life Science
Ribosomal RNA (rRNA) accounts for majority of total cellular RNA, and efficient depletion of rRNA is an important step in RNA-sequencing (RNA-seq) for good transcript coverage and cost effectiveness. KAPA RiboDesigner is Roche’s latest custom probe design solution that helps the KAPA RNA HyperPrep RiboErase users to easily design custom probes for studying the transcriptomics of multiple species without going through the complex, time-consuming, and costly manual probe design process.
In this webinar, we discussed:
Presenter: Drew Cheney, Field Application Specialist, Roche Sequencing and Life Science
RNA-sequencing (RNA-seq) and the study of transcriptomes have become essential in both molecular and clinical research. Many researchers and sequencing service providers have found RNA-seq difficult to adopt due to various challenges.
In this webinar, we discussed:
Presenters:
Jonathan Nowacki, Senior Technical Services Consultant - Bioinformatics, Roche Sequencing and Life Science;
The right set of NGS tools can save your business— or your lab— valuable sequencing resources. To maximize efficiency and effectiveness, ask yourself: (1) Which approach is best for answering specific experimental questions? (2) Is this the most cost-effective method to get the job done?
In this webinar, we discussed:
Presenters:
Teri Rambo Mueller, Field Applications Consultant, Roche Sequencing and Life Science;
Daniel Kim, Instrument Sales Specialist, Roche Sequencing and Life Science
In the age of precision medicine, molecular testing by next-generation sequencing and PCR are transforming oncology decision making. The clinical value of that molecular testing is significantly enhanced by precise dissection of formalin-fixed paraffin-embedded tissue samples.
The AVENIO Millisect System is an automated, high-performance FFPE tissue-dissection system that enables the precise and consistent recovery of tissue areas of interest for molecular pathology. Easily integrated into a variety of clinical workflow configurations, the AVENIO Millisect System can help labs efficiently extract more clinically relevant information from every sample. Accurate dissection improves the results of diagnostic testing by reducing false negatives and allowing identification of additional potential therapeutic targets.
In this webinar, we:
Presenter: Drew Cheney, Field Application Specialist, Roche Sequencing and Life Science
Building on over 10 years of design expertise, Roche is pleased to introduce the KAPA Target Enrichment Portfolio. These new probes for hybridization-based target enrichment are available in the new KAPA HyperExome or in Custom Panels that you develop using HyperDesign , our new online development tool.
In this webinar, we:
Presenter: Dr. Sarah Trusiak, PhD, Senior Applications Scientist Roche Sequencing and Life Science
Since the emergence of the SARS-CoV-2 virus in late 2019, many research groups have pivoted their focus to studying the virus and its associated disease, COVID-19. RNA-seq offers a powerful, high-throughput tool for studying both the genome of RNA viruses, such as SARS-CoV-2, and the resulting transcriptional changes in a host during viral infection.
In this webinar, we: